These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 24968292)
1. [Contemporary possibilities of non-oral estrogen-progestin contraception]. Driák D Cas Lek Cesk; 2014; 153(3):142-5. PubMed ID: 24968292 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response. Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746 [TBL] [Abstract][Full Text] [Related]
3. Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database. Murphy PA; Brixner D Contraception; 2008 Apr; 77(4):257-63. PubMed ID: 18342648 [TBL] [Abstract][Full Text] [Related]
11. Role of progestins in contraception. Erkkola R; Landgren BM Acta Obstet Gynecol Scand; 2005 Mar; 84(3):207-16. PubMed ID: 15715527 [TBL] [Abstract][Full Text] [Related]
12. Innovations in contraception: a review. Zurawin RK; Ayensu-Coker L Clin Obstet Gynecol; 2007 Jun; 50(2):425-39. PubMed ID: 17513928 [TBL] [Abstract][Full Text] [Related]
13. Progestins for contraception: modern delivery systems and novel formulations. Royer PA; Jones KP Clin Obstet Gynecol; 2014 Dec; 57(4):644-58. PubMed ID: 25314087 [TBL] [Abstract][Full Text] [Related]
14. Contraceptive implants: an overview and update. Isley MM; Edelman A Obstet Gynecol Clin North Am; 2007 Mar; 34(1):73-90, ix. PubMed ID: 17472866 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of metrorrhagia, breakthrough bleeding and spotting under contraceptives]. Gompel A J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S356-64. PubMed ID: 19268214 [TBL] [Abstract][Full Text] [Related]
16. Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH). Sacco S; Merki-Feld GS; Ægidius KL; Bitzer J; Canonico M; Gantenbein AR; Kurth T; Lampl C; Lidegaard Ø; Anne MacGregor E; MaassenVanDenBrink A; Mitsikostas DD; Nappi RE; Ntaios G; Paemeleire K; Sandset PM; Terwindt GM; Vetvik KG; Martelletti P; J Headache Pain; 2018 Aug; 19(1):76. PubMed ID: 30171365 [TBL] [Abstract][Full Text] [Related]
17. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study. Merz M; Kroll R; Lynen R; Bangerter K Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585 [TBL] [Abstract][Full Text] [Related]
18. [Hormonal contraception]. Van Cauwenberge JR Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074 [TBL] [Abstract][Full Text] [Related]
19. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785 [TBL] [Abstract][Full Text] [Related]
20. Hormonal contraception: state of the art and future perspectives. Benagiano G; Bastianelli C; Farris M Minerva Ginecol; 2007 Jun; 59(3):241-70. PubMed ID: 17576403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]